en · de · es
aod-9604-notes.peptides4962.com › Wiki › Research And Regulatory Context — Explained

Research And Regulatory Context — Explained

By Editorial Desk · published 2025-07-05 · last reviewed 2025-08-04 · Wiki

peptide research raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2025-08-04 and is reviewed periodically as new material appears.

Research and Regulatory Context

AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.

Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.

Identity and Research Origin

AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.

Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.

Aod-9604 at a glance

PropertyValueNotes
Regulatory statusNot approved as a medicineMajor agencies have not authorized it for therapeutic use.
Anti-doping statusProhibited in sportListed among peptide hormones and related substances.
Primary research areaMetabolic and body-composition effectsStudies often examine fat mass or lipid markers.
Human evidenceLimited and mixedPublic data do not establish clinical efficacy.
Analytical detectionLC-MS and immunoassaysMethods vary in sensitivity and validation.

Background And Research Context

The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.

In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.

Related pages on this site

Identity And Research Background

AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.

AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.

AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.

Notes from published material

== Pharmacokinetics == The major source of retinoids in the human diet is plant pigments such as carotenes and retinyl esters derived from animal sources. Retinyl esters are transported through the chylomicron pathway to the liver or fat tissue while retinol or carotenes are transported from the enterocytes to the liver and are processed into retinyl esters by LRAT for storage. Most synthetic retinoids are absorbed when taken orally, while topical retinoids cannot diffuse through the skin barrier unless it is compromised. All classes of retinoid bind to many proteins. Natural retinoids such as retinol and retinyl esters bind to carrier proteins such as RBP4, chylomicrons and VLDL while synthetic retinoids likely bind to these and other proteins. First generation retinoids are rapidly metabolized by Cytochrome p450 enzymes, typically of the Cyp26 family.

== Biomedical applications == The oldest application is also the simplest: the surgical suture. Braided silk is easy to handle and holds a knot securely, and it remains in clinical use, although it can provoke a tissue reaction and lose strength over time, and synthetic threads have replaced it in some procedures. Porous silk scaffolds serve as temporary frameworks for regrowing tissue. Because their strength can be set and their degradation slowed, they suit tissues that either bear load or heal slowly—bone, cartilage, skin, and connective tissues such as ligament and tendon, where the toughness of silk is an advantage. Cells are seeded onto the scaffold, which provides mechanical support while they become established and is gradually replaced by the body's own tissue. Silk films, gels and particles can hold a drug and release it slowly. The mild, water-based processing is the principal advantage: sensitive drugs and proteins survive incorporation, and release can be slowed by increasing the beta-sheet content of the surrounding silk. Silk coatings have also been used to stabilise vaccines and other biologics against heat. Thin silk films are transparent, can be moulded with fine surface patterns and dissolve in the body, a combination well suited to biodegradable electronics and optics. Silicon components have been fabricated on silk films designed to conform to tissue and then dissolve once their function is complete, an approach known as transient or bioresorbable electronics. Silk has also been formed into lenses, diffraction gratings and sensors.

Tonic water is often used as a drink mixer for cocktails, especially gin and tonic. Vodka tonic is also popular. Tonic water with lemon or lime juice added is often known as bitter lemon or bitter lime. It is popular for its signature bittersweet taste. Another use of tonic water is in coffee. The espresso and tonic was created in Helsingborg, Sweden, at Koppi Roasters after a staff party where they mixed tonic water, syrup, and an espresso. Since 2007, the drink has grown in popularity in Scandinavia, Europe, and the United States.

Sources: en.wikipedia.org

Background from the literature

Epididymis evolution from reptiles to mammals Epididymal hypertension – Condition that arises during human sexual arousal when seminal fluid is not ejaculatedPages displaying short descriptions of redirect targets List of distinct cell types in the adult human body

=== Etymology === DuPont went through an extensive process to generate names for its new product. In 1940, John W. Eckelberry of DuPont stated that the letters "nyl" were arbitrary, and the "on" was copied from the suffixes of other fibers such as cotton and rayon. A later publication by DuPont (Context, vol. 7, no. 2, 1978) explained that the name was originally intended to be "No-Run" ("run" meaning "unravel") but was modified to avoid making such an unjustified claim. Since the products were not really run-proof, the vowels were swapped to produce "nuron", which was changed to "nilon" "to make it sound less like a nerve tonic". For clarity in pronunciation, the "i" was changed to "y". A persistent urban legend exists that the name is derived from "New York" and "London"; however, no organization in London was ever involved in the research and production of nylon.

octanol-water partition coefficient log P not greater than 3 molecular mass less than 300 daltons not more than 3 hydrogen bond donors not more than 3 hydrogen bond acceptors not more than 3 rotatable bonds

=== Non-TNFi biologics === Non-TNFi "biologic" drugs used in the treatment of ankylosing spondylitis include drugs that target different pathways involved in the inflammatory process. Two of the most important drugs in this class target IL-17, an important part of the inflammatory system: secukinumab and ixekizumab. They are often considered in cases where TNFi drugs are not effective or cause too many side effects. Additionally, they may sometimes be used as an adjunct to a TNFi when symptoms persist, but improve, while the patient is on the TNFi. The choice of a specific non-TNFi biologic depends on various factors, including the patient's medical history, preferences, and the recommendations of the healthcare provider. Ustekinumab has frequently been used as a second-line therapy for AS, but it has recently been scrutinized for a lack of efficacy, and is no longer recommended.

Sources: en.wikipedia.org

Reference notes

=== Reproduction and lifespan === Breeding season takes place between August and December. The coastal taipan is oviparous, laying a clutch of 7 to 20 eggs. The eggs take 60 to 80 days to hatch, with the newly hatched snakes ranging from 30 to 34 cm (12 to 13 in) in length. The young grow quickly, averaging 6.7 cm (2.6 in) a month, and reaching a length of 1.0 m (3.3 ft) in a year. Male coastal taipans reach sexual maturity when they reach 80 cm in length, which they reach around 16 months of age, while females are able to breed when they are around 100 cm long, around 28 months old.

Before it can be eaten, salt cod must be rehydrated and desalinated by soaking in cold water for one to three days, changing the water two to three times a day. In Europe, the fish is prepared for the table in a wide variety of ways, most commonly with potatoes and onions in a casserole, as croquettes, or as battered, deep-fried pieces. In France, brandade de morue is a popular baked gratin dish of potatoes mashed with rehydrated salted cod, seasoned with garlic and olive oil. Some Southern France recipes skip the potatoes altogether and blend the salted cod with seasonings into a paste. many recipes are found in France, like Grand aïoli, Raïto or Gratin de morue. There is a particularly wide variety of salt cod dishes in Portuguese cuisine. In Greece, fried cod is often served with skordalia. There are also numerous, varied specialities in north-eastern Italy. In the south Italian region of Campania, dried and salted cod under the name baccalà is common enough that fish markets have specially designated areas where water is constantly run over the dried fish. It is also sold in supermarkets, already reconstituted, permitting quick domestic preparations wherein it is fried, boiled to make a salad or casserole, or simmered with flavourings. Salt cod is part of many European celebrations of the Christmas Vigil, and the modern Italian-American Feast of the Seven Fishes. In several islands of the West Indies, it forms the basis of the common dish saltfish. In Jamaica, the national dish is ackee and saltfish.

=== Tanning === Potassium alum is used in leather tanning, in order to remove moisture from the hide and prevent rotting. Unlike tannic acid, alum doesn't bind to the hide and can be washed out of it.

== Uses == Coca leaves have been used by Andean civilizations since ancient times. In ancient Wari culture, Inca culture, and through modern successor indigenous cultures of the Andes Mountains, coca leaves are chewed, taken orally in the form of a tea, or alternatively, prepared in a sachet wrapped around alkaline burnt ashes, and held in the mouth against the inner cheek; it has traditionally been used as an anorectic and to combat the effects of cold and altitude sickness, although its actual effectiveness has never been systematically studied. Globally, in 2019, cocaine was used by an estimated 20 million people (0.4% of adults aged 15 to 64 years). The highest prevalence of cocaine use was in Australia and New Zealand (2.1%), followed by North America (2.1%), Western and Central Europe (1.4%), and South and Central America (1.0%). Since 1961, the Single Convention on Narcotic Drugs has required countries to make recreational use of cocaine a crime. In the United States, cocaine is regulated as a Schedule II drug under the Controlled Substances Act, meaning that it has a high potential for abuse but has an accepted medical use. While rarely used medically anymore, its accepted uses include serving as a topical local anesthetic for the upper respiratory tract and as an antihemorrhagic agent to stop bleeding in the mouth, throat, and nasal cavities.

=== Traditional medicines === Parmotrema perlatum is used as a component of a herbal mixture in Ayurvedic medicine, one of several parmelioid lichen species used as charila. Referenced in ancient Ayurvedic texts and first mentioned in the Atharvaveda around 1500 BCE, charila is a lichen mixture traditionally used in India for its purported medicinal properties. It has been employed to treat various ailments, including digestive and respiratory issues, skin conditions, and reproductive health concerns, and it also serves as an ingredient in treatments for infertility. For chronic ulcers, a powder made from dried lichen, infused in pork suet, is applied externally.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 approved for medical use?

No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.

Why is AOD-9604 banned in sports?

It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.

What do human studies show?

Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.

Network